Lilly's drug lowers heart disease risk factor in just 1 dose: Study

A single dose of Eli Lilly & Co.’s experimental drug cut a risk factor that signals heart disease by 94% for almost a year, a study found. 

Related Keywords

Canada ,Montreal ,Quebec ,United States ,New York ,Philadelphia ,Pennsylvania ,Ohio ,Indiana ,Winnipeg ,Manitoba ,American ,Gordon Bluesky ,Ted Wyman ,Warren Kinsella ,Richard Clough ,William Stanback ,Paul Friesen ,Lorrie Goldstein ,Eli Lilly ,Novo Nordisk ,Steve Nissen ,Scott Billeck ,Zach Collaros ,Kyrie Wilson ,Ryan Stelter ,Winnipeg Police Service ,American Heart Association ,Amgen Inc ,Eli Lilly Co ,Postmedia Network ,Postmedia Network Inc ,Community Guidelines ,Journal Of The American Medical Association ,Gimme Stelter ,Exit Row ,Winnipeg Sun ,New York Times ,Cleveland Clinic ,Daily Headline News ,American Medical ,Unlimited Online ,Bombers Alouettes Grey Cup ,Blue Bomber Kyrie Wilson ,Montreal Alouette William ,Bomber Collaros ,Osborne Village ,Police Service ,Bannatyne Avenue ,Zone Chairperson ,Brokenhead Ojibway Nation Chief Gordon ,